LITMIR.BIZ

Скачать книгу

fluid-bed coating: preparation, characterization and in vitro redispersibility. Int. J. Nanomedicine, 6, 795–805, 2011.

      3. Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K., Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm., 212, 233–246, 2001.

      4. Raza, K., Singh, B., Singal, P., Wadhwa, S., Katare, O.P., Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf. B: Biointerfaces, 105, 67–74, 2013.

      5. Barua, S. and Mitragotri, S., Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today, 9, 223–243, 2014.

      6. Mohsin, K., Shahba, A.A., Alanazi, F.K., Lipid based self emulsifying formulations for poorly water soluble drugs-an excellent opportunity. Indian J. Pharm. Educ. Res., 46, 88–96, 2012.

      7. Gupta, M., Agrawal, U., Vyas, S.P., Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin. Drug Deliv., 9, 783–804, 2012.

      8. Raphael, A.P., Garrastazu, G., Sonvico, F., Prow, T.W., Formulation design for topical drug and nanoparticle treatment of skin disease. Ther. Deliv., 6, 197–216, 2015.

      9. Smith, A. and Hunneyballlan, M., Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm., 30, 215–220, 1986.

      10. Siekmann, B. and Westesen, K., Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett., 1, 123–126, 1992.

      11. Schmidt, P.C., Pharmazeutische Technologie: Moderne Arzneiformen. Lehrbuch für Studierende der Pharmazie, Nachschlagewerk für Apotheker in Offizin, Krankenhaus und Forschung. Von R. H. Müller und G. E. Hildebrand. 348 Seiten, 117 Abbildungen, 57 Tabellen. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1997, pp. 323–323, Pharm UnsererZeit, Germany, 1997.

      12. Mann, E.A., Gurny, R., Doelker, E., Drug loaded nanoparticles-preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm., 39, 173–191, 1993.

      13. Patidar, A., Thakur, D.A., Kumar, V., Verma, J., A review on novel lipid based nanocarriers. Int. J. Pharm. Pharm. Sci., 2, 3035, 2010.

      14. Pinto, J.F. and Muller, R.H., Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs. Pharmazie, 54, 506–509, 1999.

      15. Sznitowska, M., Gajewska, M., Janicki, S., Radwanska, A., Lukowski, G., Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur. J. Pharm. Biopharm., 52, 159–163, 2001.

      16. Muller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 54, 131–155, 2002.

      17. Olbrich, C., GeBner, A., Kayser, O., Muller, R.H., Lipid drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediacetu-rate. J. Drug Targeting, 10, 387–396, 2002.

      18. Mueller., E.A., Kovarik, J.M., vanBree, J.B., Tetzloff, W., Grevel, J., Kutz, K., Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm. Res., 11, 301–304, 1994.

      19. Sawant, R.R. and Torchilin, V.P., Challenges in Development of Targeted Liposomal Therapeutics. AAPS J., 14, 303–315, 2012.

20. Kong, X., Yu, K., Yu, M., Feng, Y., Wang, J., Li, M., A novel multifunctional poly (amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted 22 Nanopharmaceutical Advanced Delivery Systems delivery of the chemotherapy drug 10-hydroxycamptothecin. Int. J. Pharm., 465, 378–387, 2014.

      21. Tila, D., Ghasemi, S., Yazdani-Arazi, S.N., Ghanbarzadeh, S., Functional liposomes in the cancer-targeted drug delivery. J. Biomater. Appl., 30, 3–16, 2015.

      22. Deamer, D.W., From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921-2010. FASEB J., 24, 1308–1310, 2010.

      23. Swaminathan, J. and Ehrhardt, C., Liposomal delivery of proteins and peptides. Expert Opin. Drug Deliv., 9, 1489–1503, 2012.

      24. Garg, T.K. and Goyal, A., Liposomes: targeted and controlled delivery system. Drug Deliv., 4, 62–71, 2014.

      25. Xing, H., Hwang, K., Lu, Y., Recent Developments of Liposomes as Nanocarriers for theranostic applications. Theranostic, 6, 1336–1352, 2016.

      26. Blume, G. and Cevc, G., Molecular mechanism of lipid vesicles longevity in-vivo. Biochim. Biophys. Acta, 1146, 157–168, 1993.

      27. Allen, T.M. and Cullis, P.R., Liposomal drug delivery system from concept to clinical applications. Adv. Drug Deliv., 65, 36–48, 2013.

      28. Kaneda, Y., Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev., 43, 197–205, 2000.

      29. Samad, A., Sultana, Y., Aqil, M., Liposomal drug delivery systems: an update review. Curr. Drug Deliv., 4, 297–305, 2007.

      30. Couvreur, P., Dubernet, C., Puisieux, F., Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm., 41, 2–13, 1995.

      31. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 70, 1–20, 2001.

      32. Smith, A., Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm., 30, 215–220, 1986.

      33. Muller, R.H., Mader, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm., 50, 1, 161–177, 2000.

      34. Mehnert, W. and Mader, K., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165–196, 2001.

      35. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., Lou, H., Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release, 133, 238–244, 2009.

      36. Uner, M. and Yener, G., Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine, 3, 289–300, 2007.

      37. Harde, H., Das, M., Jain, S., Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv., 8, 1407–1424, 2011.

      38. M.R. Gasco, Method for Producing Solid Lipid Microspheres Having a Narrow Size Distribution, US Patent-US5250236A, 1993.

      39. Ochekpe, N.A., Olorunfemi, P.O., Ngwuluka, N.C., Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Trop. J. Pharm., 8, 275–287, 2009.

      40. Khurana, S., Utreja, P., Tiwary, A., Jain, N., Jain, S., Nanostructured lipid carriers and their application in drug delivery. Int. J. Biomed. Eng. Technol., 2, 152–171, 2009.

      41. Iqbal, M.A., Md, S., Sahni, J.K., Baboota, S., Dang, S., Ali, J., Nanostructured lipid carriers system: Recent advances in drug delivery. J. Drug Targeting, 10, 813–830, 2012.

      42. Ranpise, N.S., Korabu, S.S., Ghodake, V.N., Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf. B Biointerfaces, 116, 81–87, 2014.

43. Tiwari, R. and Pathak, K., Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm., 415, 232–243, 2011.

      44. Nanjwade, B.K., Patel, D.J., Udhani,

Скачать книгу